Physician profile
Edward E Bratton
NPI 1649282112
$2,050.27
in general payments reported to CMS, 2019-2025
12 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $320 · 2021: $469 · 2022: $33.74 · 2023: $406 · 2024: $277 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $494.68 | 2019-2023 | Physio-Stim, Spinal-Stim |
| Horizon Therapeutics Plc | $384.88 | 2020-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $211.59 | 2025 | |
| Bone Support INC. | $154.86 | 2024 | Cerament G, Ceramentbone Void Filler |
| Aroa Biosurgery Incorporated | $144.74 | 2023 | |
| Globus Medical, INC. | $128.23 | 2025 | Senza |
| Convatec INC. | $122.12 | 2024 | |
| Organogenesis INC. | $119.15 | 2021 | |
| Merck Sharp & Dohme LLC | $108.97 | 2019 | |
| Smith+Nephew, INC. | $107.38 | 2021 | |
| Wright Medical Technology, INC. | $39.93 | 2020 | |
| Nevro Corp. | $33.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Bratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.